GlassScriptPhysician profile
Arya Bekhradi
NPI 1396371290
$5,621.63
in general payments reported to CMS, 2019-2025
14 companies · $3,200 in 2025
The $3,200 reported for 2025 was more than what 89% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $213 · 2023: $665 · 2024: $1,543 · 2025: $3,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,848 · Travel and Lodging: $1,561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,847.53 |
| Travel and Lodging | $1,560.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,946.68 | 2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $1,184.13 | 2024-2025 | General - Therapies, General - Pain Management, Wavewriter Alpha Prime 16 |
| Saluda Medical Americas, INC. | $769.93 | 2023-2025 | Evoke, Evoke Scs |
| Nevro Corp. | $360.08 | 2023-2024 | Senza |
| Medtronic, INC. | $346.43 | 2024-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Abbvie INC. | $195.07 | 2022 | |
| Mml US, INC. | $179.27 | 2025 | Reactiv8 |
| Merz Pharmaceuticals, LLC | $125.00 | 2023 | Xeomin |
| Nalu Medical, INC. | $122.28 | 2023 | Nalu Neurostimulation System |
| Averitas Pharma INC. | $122.10 | 2024 | Qutenza |
| Spr Therapeutics, INC | $120.51 | 2024 | Sprint Pns System |
| Stryker Corporation | $104.76 | 2025 | Spinejack, Mild Device Kit, Multigen 2 |
| Avanos Medical | $27.03 | 2023 | On-Q* Pump and Accessories |
| Collegium Pharmaceutical, INC. | $18.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arya Bekhradi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.